---
title: "Modern Healthcare Technology Wins Independent Backing for 2026 Master Lease Deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281025303.md"
description: "Modern Healthcare Technology Holdings Limited has received independent shareholder approval for its 2026 Master Lease Agreement, with 100% of votes in favor at an extraordinary general meeting on March 30, 2026. This approval reduces governance risks and supports the company's long-term occupancy commitments. The latest analyst rating for the stock (HK:0919) is a Hold, with a price target of HK$0.09. The company operates in the healthcare services and technology sector, with a current market cap of HK$75.98M and a year-to-date price performance of 12.00%."
datetime: "2026-03-30T13:00:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281025303.md)
  - [en](https://longbridge.com/en/news/281025303.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281025303.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/281025303.md) | [繁體中文](https://longbridge.com/zh-HK/news/281025303.md)


# Modern Healthcare Technology Wins Independent Backing for 2026 Master Lease Deal

### End of Quarter Sale - 50% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

An update from Modern Healthcare Technology Holdings Limited ( (HK:0919) ) is now available.

Independent shareholders of Modern Healthcare Technology Holdings Limited have approved the company’s 2026 Master Lease Agreement, along with the related transaction arrangements and annual caps, at an extraordinary general meeting held on March 30, 2026. The resolution passed by poll with 100% of votes cast in favour, clearing the way for the board to implement the leasing framework that will govern key premises used in the group’s operations.

The approval, given by the quarter of the company’s share capital held by independent shareholders, reduces governance risk around connected transactions and affirms support for the group’s long-term occupancy and cost commitments. With all but one director attending the meeting and an external scrutineer overseeing the poll, the process underpins regulatory compliance and provides clarity for stakeholders on the company’s lease structure for the coming period.

The most recent analyst rating on (HK:0919) stock is a Hold with a HK$0.09 price target. To see the full list of analyst forecasts on Modern Healthcare Technology Holdings Limited stock, see the HK:0919 Stock Forecast page.

**More about Modern Healthcare Technology Holdings Limited**

Modern Healthcare Technology Holdings Limited is a Hong Kong-listed company incorporated in the Cayman Islands, operating in the healthcare services and technology sector. The group’s activities centre on providing healthcare-related services and solutions in its core Asian markets, and it is controlled by chairperson Dr. Tsang Yue, Joyce, who holds a majority stake together with her associates.

**YTD Price Performance:** 12.00%

**Average Trading Volume:** 992,862

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$75.98M

### Related Stocks

- [MODERNHEALTHTEC (00919.HK)](https://longbridge.com/en/quote/00919.HK.md)

## Related News & Research

- [Modern Healthcare Tech Calls EGM to Approve 2026 Master Lease Arrangements](https://longbridge.com/en/news/279019231.md)
- [Culpeo Minerals Sets May 7 AGM and Urges Early Proxy Voting](https://longbridge.com/en/news/281449270.md)
- [Nyfosa Calls 2026 AGM, Combining Physical and Postal Voting](https://longbridge.com/en/news/281153755.md)
- [Diales Group Sets Updated Voting Share Capital for Disclosure Thresholds](https://longbridge.com/en/news/281146874.md)
- [MEKO calls 2026 AGM with in-person and postal voting options](https://longbridge.com/en/news/281364262.md)